Table 1 Characteristics of patients before and after propensity score matching
Pre PSM | Post PSM | ||||||
|---|---|---|---|---|---|---|---|
RARP, Pre PSM N = 127 | CIRT, Pre PSM N = 190 | p-Value | RARP, Post PSM N = 101 | CIRT, Post PSM N = 101 | p-Value | ||
Age (mean ± S.D.) | 64.9 ± 6.51 | 65 ± 6.61 | p = 0.589 | 65.1 ± 5.87 | 65.3 ± 6.47 | p = 0.800 | |
PSA (mean ± S.D.) | 7.24 ± 3.40 | 5.71 ± 1.87 | p < 0.001 | 6.34 ± 2.46 | 6.31 ± 2.07 | p = 0.939 | |
EPIC Sexual Function summary score (mean ± S.D.) | 46.7 ± 15.2 | 46.9 ± 15.6 | p = 0.898 | 46.4 ± 15.6 | 48.2 ± 16.2 | p = 0.438 | |
T stage; n, (%) | T1 | 16 (12.6%) | 76 (40.0%) | p < 0.001 | 16 (15.8) | 17 (16.8) | p = 0.982 |
T2 | 103 (81.0%) | 113 (59.5%) | 84 (83.2) | 83 (82.2) | |||
T3 | 8 (6.3%) | 1 (0.5%) | 1 (1.0) | 1 (1.0) | |||
Gleason Score; n, (%) | 6 | 8 (6.3%) | 49 (25.8%) | p < 0.001 | 7 (6.9) | 28 (27.7) | p < 0.001 |
7 | 96 (75.6%) | 140 (73.7%) | 78 (77.2) | 72 (71.3) | |||
8 | 17 (13.4%) | 1 (0.5%) | 12 (11.9) | 1 (1.0) | |||
9 | 6 (4.7%) | 0 (0%) | 4 (4.0) | 0 (0) | |||
Nerve sparing; n, (%) | (+) | 99 (78.0%) | NA | NA | 76 (75.2%) | NA | NA |
(-) | 28 (22.0%) | NA | 25 (24.8%) | NA | |||